Patients Discontinuing Weight-Loss Jabs Put On Pounds at a Quadrupled Rate Compared to People Using Diet and Exercise

Fresh analysis suggests that individuals who stop using blockbuster slimming jabs like Wegovy and Mounjaro tend to recover reduced body mass far faster than those who halt conventional lifestyle regimens.

Findings released in a prominent health publication shows that while overweight people frequently drop substantial amounts of their body weight while on the medication, the mass comes back at an estimated rate of nearly a kilo each month once they quit.

"Individuals purchasing these drugs should be cognizant of the potential of rapid weight regain when the treatment concludes," cautioned lead investigator Dr. Susan Jebb.

Such speed of regain implies a reversion to original weight within about 18 months.

Analyzing Therapies

The research, which looked at dozens of studies involving thousands of participants, contrasted the results of these new drugs with other pills.

The team note that people who shed pounds through dieting usually have a slower creep back—around 100 grams monthly—after stopping.

Understanding the Quick Regain

Doctors suggest the mode of action of the drugs is key to understanding the amplified weight return.

GLP-1 drugs mimic a natural hormone called glucagon-like peptide-1, which controls appetite.

"Artificially providing the hormone concentrations far above than normal may cause the body to generate a reduced amount of its own natural hormone, and could diminish sensitivity to its effects," explained Dr. Adam Collins, a nutrition researcher.

"Withdrawal of this hormone supplement leads to appetite is uncontrolled, making excessive eating much more probable."

An Ongoing Condition?

Health authorities suggest the injections for individuals with weight-linked medical conditions, alongside recommended diet and exercise modifications.

A number of clinicians argue that, considering the likelihood of weight regain, the therapy might need to be long-term.

This view is echoed by pharmaceutical companies, who state that the results "emphasize the persistent nature of obesity," akin to managing conditions like diabetes.

User Accounts

Users who have discontinued the jabs describe a powerful return of appetite.

"It was like a trigger flipping and you become extremely hungry," said a patient.

This challenge is worsened if users have not developed lasting lifestyle or habit modifications during treatment.

Growing Adoption

Figures show that a significant number of people in the UK have tried these injections in the past year, with demand continuing to grow.

• Use is more common among women compared to males.
• The 40s and 50s demographic shows the highest level of interest.
• Many obtain the drugs through private healthcare rather than the NHS.

In conclusion, clinicians emphasize that while the jabs are powerful tools for weight loss, they are not a permanent fix and maintained weight loss relies on integrated behavioural support.